Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Downgrades Adient to Peer Perform

Wolfe Research Downgrades Adient to Peer Perform

Wolfe Research analyst Rod Lache downgrades Adient (NYSE:ADNT) from Outperform to Peer Perform.

byBenzinga Newsdesk

February 9, 2023

1 minute read

Wolfe Research analyst Rod Lache downgrades Adient (NYSE:ADNT) from Outperform to Peer Perform.

Who Is Bitcoin Influencer Max Keiser?

By Khyathi Dalal

June 20, 2:58 PM

Bitcoin influencer Pete Rizzo took to social media to highlight the contributions of Max Keiser, a long-time Bitcoin (CRYPTO: BTC)

BTC

Solana DEX Developer Admits To Stealing And Gambling Away $300M Meant For Hack Victims: ‘I F***ed Up Way Too Hard’

By Aniket Verma

May 15, 4:24 AM

A core developer working for Solana-based (CRYPTO: SOL) decentralized exchange, Cypher, admitted to misappropriating funds worth more than $300 million meant to compensate victims of a sensational hack on the platform last year.

SOL

Wedbush Maintains Neutral on Lowe’s Companies, Raises Price Target to $225

By Benzinga Newsdesk

August 18, 11:14 AM

Wedbush analyst Seth Basham maintains Lowe's Companies (NYSE:LOW) with a Neutral and raises the price target from $200 to $225.

LOW

Wedbush Reiterates Outperform on Adicet Bio, Maintains $30 Price Target

By Benzinga Newsdesk

March 16, 8:38 AM

Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $30 price target.

ACET

Wolfe Research Downgrades Adient to Peer Perform

Related Posts

Who Is Bitcoin Influencer Max Keiser?

Solana DEX Developer Admits To Stealing And Gambling Away $300M Meant For Hack Victims: ‘I F***ed Up Way Too Hard’

Wedbush Maintains Neutral on Lowe’s Companies, Raises Price Target to $225

Wedbush Reiterates Outperform on Adicet Bio, Maintains $30 Price Target